AKR1C3-IN-12 | MedChemExpress (MCE)

AKR1C3-IN-12 (compound 2j) is an aldo-keto reductase 1C3 (AKR1C3) inhibitor with an IC50 of 27 nM. AKR1C3-IN-12 enhances the efficacy of Gemcitabine and Cisplatin in bladder cancer[1].

Trivial name AKR1C3-IN-12
Catalog Number HY-163323
Research Area Cancer
CAS# 891075-67-5
Purity ≥98.0%
SMILES O=C(C1=CC2=C(OC1=N)C(O)=CC=C2)NC3=CC=C(C)C=C3
Size 1 mg
Supplier Page https://www.medchemexpress.com/akr1c3-in-12.html